Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information... Show more
FLGT is expected to report earnings to fall 259.21% to -22 cents per share on February 26
Q4'25
Est.
$-0.22
Q3'25
Beat
by $0.36
Q2'25
Beat
by $0.25
Q1'25
Beat
by $0.12
Q4'24
Beat
by $0.43
The last earnings report on November 07 showed earnings per share of 14 cents, beating the estimate of -21 cents. With 404.98K shares outstanding, the current market capitalization sits at 898.93M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. FLGT showed earnings on November 07, 2025. You can read more about the earnings report here.